Sabinsa Studies On Gugulipid

1. Open Field Study to Evaluate  Gugulipid in the Treatment of Dyslipidemias - Department of Veterans Affairs Medical Center (Arizona)

The purpose of this study is to investigate the effect of Gugulipid on serum lipids (i.e. cholesterol, LDL, HDL, triglycerides) in individuals with dyslipidemias. All individuals are volunteers who have serum cholesterol levels > 200 mg/dL. Serum cholesterol levels and the levels of other parameters are measured prior to and after treatment with Gugulipid.

2. IND Study #59, 172 - Randomized, Double-Blind,   Placebo-Controlled Trial Evaluating the Safety and  Efficacy of Gugulipid in Americans with Hypercholesterolemia - University of Pennsylvania.

The purpose of this study is to evaluate the efficacy and safety of Gugulipid in Americans with dyslipidemias. The participants of the study are volunteers, 18 years and older, who have LDL levels between 130-190 mg/dL and triglycerides less than 400 mg/dL. The safety of the study will be measured by self-reported adverse events. In addition hematological and blood biochemistry parameters will be assessed throughout the study to monitor safety and efficacy. The efficacy of Gugulipid will be measured as a percent change from baseline in total cholesterol, LDL, HDL, and triglycerides in Gugulipid versus placebo groups.

"These statements have not been evaluated by the Food and Drug Administration.
This product is not intended to diagnose, cure, or prevent any disease"


Copyright © Sabinsa Corporation. All Rights Reserved | Disclaimer